{"transactions":[{"id":2693343,"issuer":{"id":110211,"kind":"organization","name":"Avenir Wellness Solutions, Inc.","symbol":"AVRW"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-05-27T19:34:04.000Z","date":"2020-09-23","kind":"grant","acquired":true,"shares":61654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received restricted stock units under the equity incentive plan. Vesting occurs within a one-year term or until the next annual meeting of shareholders. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. This late filing is due to an inadvertent administrative error and not any error of the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received restricted stock units under the equity incentive plan. Vesting occurs within a one-year term or until the next annual meeting of shareholders. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. This late filing is due to an inadvertent administrative error and not any error of the reporting person."}],"balance_after":61654,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":61654},"source":{"system":"sec-edgar","filing":"0001477932-21-003645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643301/000147793221003645/form4.xml","form_type":"4"}},{"id":2693342,"issuer":{"id":110211,"kind":"organization","name":"Avenir Wellness Solutions, Inc.","symbol":"AVRW"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T19:34:04.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":17601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock award. This late filing is due to an inadvertent administrative error and not any error of the reporting person."}],"balance_after":17601,"source":{"system":"sec-edgar","filing":"0001477932-21-003645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643301/000147793221003645/form4.xml","form_type":"4"}},{"id":3096577,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2020-06-30T20:14:44.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 5, 2019, the reporting person received options to purchase 39,567 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":75000,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0001213900-20-016315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020016315/ownership.xml","form_type":"4"}},{"id":3096576,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T20:14:44.000Z","date":"2020-06-30","kind":"other","acquired":true,"shares":29,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":9817,"source":{"system":"sec-edgar","filing":"0001213900-20-016315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020016315/ownership.xml","form_type":"4"}},{"id":3190858,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T20:15:52.000Z","date":"2020-03-31","kind":"other","acquired":true,"shares":29,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":9788,"source":{"system":"sec-edgar","filing":"0001213900-20-008214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020008214/ownership.xml","form_type":"4"}},{"id":3327138,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:10:08.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":29,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":9759,"source":{"system":"sec-edgar","filing":"0000905718-20-000012","document":"delmarph_fm4dec312019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000012/delmarph_fm4dec312019.xml","form_type":"4"}},{"id":3403151,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T20:20:35.000Z","date":"2019-09-30","kind":"other","acquired":true,"shares":29,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":9730,"source":{"system":"sec-edgar","filing":"0000905718-19-000813","document":"delmarph_fm4sept302019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000813/delmarph_fm4sept302019.xml","form_type":"4"}},{"id":3409878,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T21:45:35.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":35000,"price":0.6784,"value":23744.0,"ownership":{"direct":false,"nature":"Held by Registered Retirement Income Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6551 to $0.68 per share, inclusive. The reporting person undertakes to provide to DelMar Pharmaceuticals, Inc., any security holder of DelMar Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4/A amends the Form 4 filed by the reporting person on September 16, 2019 solely to amend the disclosure of the shares beneficially owned as of such date by the reporting person."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000905718-19-000779","document":"delmarph_fm4amsept132019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000779/delmarph_fm4amsept132019.xml","form_type":"4/A","original_submission_date":"2019-09-16"}},{"id":3413888,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-16T20:22:03.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":35000,"price":0.6784,"value":23744.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6551 to $0.68 per share, inclusive. The reporting person undertakes to provide to DelMar Pharmaceuticals, Inc., any security holder of DelMar Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":44701,"source":{"system":"sec-edgar","filing":"0000905718-19-000777","document":"delmarph_fm4sept132019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000777/delmarph_fm4sept132019.xml","form_type":"4"}},{"id":3419573,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:49:11.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":35433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":35433,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":35433},"source":{"system":"sec-edgar","filing":"0000905718-19-000769","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000769/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3419572,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:49:11.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":39567,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0000905718-19-000769","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000769/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3474705,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-01T20:17:27.000Z","date":"2019-06-28","kind":"other","acquired":true,"shares":29,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 8, 2019, the issuer effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":9701,"source":{"system":"sec-edgar","filing":"0001213900-19-011876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019011876/ownership.xml","form_type":"4"}},{"id":3544351,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2019-05-01T22:29:05.000Z","date":"2019-04-30","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."}],"balance_after":0,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-19-007623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019007623/ownership.xml","form_type":"4"}},{"id":3571947,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T20:27:40.000Z","date":"2019-03-29","kind":"other","acquired":true,"shares":282,"price":0.49,"value":138.18,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":96711,"source":{"system":"sec-edgar","filing":"0001213900-19-005488","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019005488/ownership.xml","form_type":"4"}},{"id":3713257,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T23:17:38.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":282,"price":0.3419,"value":96.4158,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":96429,"source":{"system":"sec-edgar","filing":"0001213900-19-000051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019000051/ownership.xml","form_type":"4"}},{"id":3766900,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-11-13T21:35:34.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on December 8, 2018."}],"balance_after":40000,"derivative":{"exercise_price":0.6099,"expiration_date":"2028-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-18-015507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018015507/ownership.xml","form_type":"4"}},{"id":3804332,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T20:05:51.000Z","date":"2018-09-28","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":96147,"source":{"system":"sec-edgar","filing":"0001213900-18-013294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018013294/ownership.xml","form_type":"4"}},{"id":3875077,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T20:36:39.000Z","date":"2018-06-29","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"Held by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":95865,"source":{"system":"sec-edgar","filing":"0001213900-18-008708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018008708/ownership.xml","form_type":"4"}},{"id":3973131,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T20:02:55.000Z","date":"2018-03-30","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock"}],"balance_after":95583,"source":{"system":"sec-edgar","filing":"0001213900-18-003979","document":"f4033018bell_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018003979/f4033018bell_delmar.xml","form_type":"4"}},{"id":4112181,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T21:58:08.000Z","date":"2017-12-31","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"by Onbelay Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock"}],"balance_after":95301,"source":{"system":"sec-edgar","filing":"0000905718-18-000014","document":"bell_form4dec312017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571818000014/bell_form4dec312017.xml","form_type":"4"}},{"id":4158149,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T21:32:43.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":18129,"price":0.81,"value":14684.49,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $0.8086 to $0.81. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":95019,"source":{"system":"sec-edgar","filing":"0001213900-17-012293","document":"f4111517bell_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017012293/f4111517bell_delmar.xml","form_type":"4"}},{"id":4158148,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T21:32:43.000Z","date":"2017-11-15","kind":"purchase","acquired":true,"shares":1871,"price":0.81,"value":1515.51,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.7997 to $0.84. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":76890,"source":{"system":"sec-edgar","filing":"0001213900-17-012293","document":"f4111517bell_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017012293/f4111517bell_delmar.xml","form_type":"4"}},{"id":4197773,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T23:55:03.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":75019,"source":{"system":"sec-edgar","filing":"0001213900-17-010214","document":"f4092917bell_delmarpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017010214/f4092917bell_delmarpharm.xml","form_type":"4"}},{"id":4245660,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Exchangeable Shares","published_at":"2017-08-03T01:02:20.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":25000,"price":2,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-17-008160","document":"f4080117bell_delmar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017008160/f4080117bell_delmar.xml","form_type":"4"}},{"id":4245659,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-03T01:02:20.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."}],"balance_after":74737,"source":{"system":"sec-edgar","filing":"0001213900-17-008160","document":"f4080117bell_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017008160/f4080117bell_delmar.xml","form_type":"4"}},{"id":4259070,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2017-07-12T01:33:02.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."}],"balance_after":200000,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-17-007474","document":"f4070717bell_delmarpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007474/f4070717bell_delmarpharma.xml","form_type":"4"}},{"id":4259069,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2017-07-12T01:33:02.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12,000 options vest on June 30, 2018, and 3,000 options vest each three months thereafter starting September 30, 2018."}],"balance_after":36000,"derivative":{"exercise_price":2.11,"exercise_date":"2020-06-30","expiration_date":"2027-07-07","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001213900-17-007474","document":"f4070717bell_delmarpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007474/f4070717bell_delmarpharma.xml","form_type":"4"}},{"id":4264459,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T18:24:15.000Z","date":"2017-06-30","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":49737,"source":{"system":"sec-edgar","filing":"0001213900-17-007141","document":"f4063017bell_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007141/f4063017bell_delmarpharma.xml","form_type":"4"}},{"id":4271064,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-28T15:30:17.000Z","date":"2017-06-26","kind":"purchase","acquired":true,"shares":4167,"price":3.6,"value":15001.2,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $20,000. Reported price is based on exchange rate of 0.75."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":49455,"source":{"system":"sec-edgar","filing":"0001213900-17-006880","document":"f4062617bell_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017006880/f4062617bell_delmarpharma.xml","form_type":"4"}},{"id":4289801,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-07T15:46:29.000Z","date":"2017-06-06","kind":"purchase","acquired":true,"shares":10000,"price":2.12,"value":21200.0,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":45288,"source":{"system":"sec-edgar","filing":"0001213900-17-006217","document":"f4060617bell_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017006217/f4060617bell_delmarpharma.xml","form_type":"4"}},{"id":4365207,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-03T22:12:51.000Z","date":"2017-03-31","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":35288,"source":{"system":"sec-edgar","filing":"0001213900-17-003264","document":"f4033117bell_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017003264/f4033117bell_delmar.xml","form_type":"4"}},{"id":4507883,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T18:55:51.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":35006,"source":{"system":"sec-edgar","filing":"0001213900-17-000024","document":"f4123116bell_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017000024/f4123116bell_delmar.xml","form_type":"4"}},{"id":4584399,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":138954,"kind":"person","name":"Bell John K","position":1,"cik":"0001569585","reported_name":"Bell John K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T15:12:56.000Z","date":"2016-10-03","kind":"other","acquired":true,"shares":282,"price":3.2,"value":902.4,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Onbelay Capital Inc."}],"balance_after":34724,"source":{"system":"sec-edgar","filing":"0001213900-16-017293","document":"f4100316bell_delmarpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390016017293/f4100316bell_delmarpharm.xml","form_type":"4"}}]}